ofa semaglutide lawsuit Compound versions of GLP-1 drugs for weight loss halted by FDA FDA crackdown on off-brand Ozempic

Most patients who microdose take somewhere between 0.05 mg and 0.15 mg weekly, which comes out to roughly a quarter or half of the traditional starting dose

The overlap between GLP-1 and serotonin pathways suggests potential pharmacodynamic interactions

When the problem is not the compound Not every failure of compounded semaglutide is a compounding problem

Although rare, some people taking Ozempic or Trulicity may experience serious side effects: Severe allergic reaction Hypoglycemia (low blood sugar) Kidney problems Vision changes (diabetic retinopathy) Pancreatitis (inflammation of the pancreas) Gallbladder problems Warnings Both drugs have a black box warning from the FDA for the risk of thyroid tumors or thyroid cancer